NERVGEN PHARMA CORP. Retained Earnings
NERVGEN PHARMA CORP. (NGEN) had Retained Earnings of -CAD 146.76 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:RetainedEarnings · last filed 2026-03-31
- 2025-12-31: Retained Earnings -146.76M CAD.
- 2024-12-31: Retained Earnings -102.65M CAD.
| Period end | Retained Earnings |
|---|---|
| 2025-12-31 | -146.76M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | -102.65M CAD 40-F · filed 2026-03-31 |